Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Kazia Therapeutics Ltd (NASDAQ:KZIA)

2.57
Delayed Data
As of 3:59pm ET
 +0.1677 / +6.99%
Today’s Change
1.63
Today|||52-Week Range
7.60
-56.18%
Year-to-Date
No recent news for Kazia Therapeutics Ltd.

Today’s Trading

Previous close2.40
Today’s open2.31
Day’s range2.27 - 2.60
Volume12,305
Average volume (3 months)5,867
Market cap$11.6M
Data as of 3:59pm ET, 12/15/2017

Growth & Valuation

Earnings growth (last year)+16.21%
Earnings growth (this year)-58.23%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.24

Competitors

 Today’s
change
Today’s
% change
ABIOARCA Biopharma Inc+0.07+5.45%
OGENOragenics Inc-0.01-3.28%
IMRNImmuron Ltd0.000.00%
ANTHAnthera Pharmaceutic...+0.06+4.03%
Data as of 4:00pm ET, 12/15/2017

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$8.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Executive Director
James Garner
Director-Finance &
Administration
Gabrielle Heaton
Corporate headquarters
Hornsby, New South Wales (nsw)

Forecasts